McKeown v. Teva Pharmaceuticals USA, Inc. et al
Consolidated
Lead case: 1:21-cv-02818
Lead case: 1:21-cv-02818
| Georgia Northern District Court | |
| Judge: | Leigh Martin May |
| Case #: | 1:21-cv-05188 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Dec 20, 2021 |
| Terminated: | Dec 20, 2021 |
| Last checked: Saturday Jun 18, 2022 4:52 AM EDT |
|
Defendant
CooperSurgical, Inc
|
Represented By
|
|
Defendant
Teva Branded Pharmaceutical Products R&D, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Women's Health, LLC
|
Represented By
|
|
Defendant
The Cooper Companies, Inc.
|
Represented By
|
|
Plaintiff
Ann McKeown
|
Represented By
|
| Docket last updated: 01/28/2025 11:59 PM EST |
| Tuesday, December 17, 2024 | ||
|
utility
Submission to District Judge
Tue 12/17 9:38 AM
Submission of14 MOTION to Dismiss , to District Judge Leigh Martin May. (bnp) |
||
| Thursday, September 12, 2024 | ||
| 14 | 14
motion
Dismiss
Thu 09/12 2:16 PM
MOTION to Dismiss with Brief In Support by CooperSurgical, Inc, Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc..(Morris, Christopher) |
|
|
Att: 1
Exhibit 1
|
||
| Friday, December 15, 2023 | ||
| 13 | 13
notice
Notice of Substitution of Counsel
Fri 12/15 3:23 PM
Certification of Consent to Substitution of Counsel. Ken B. Moll replacing attorney Valeria Benitez. (Moll, Ken) |
|
| Friday, February 10, 2023 | ||
| 12 | 12
notice
Notice (Other)
Fri 02/10 1:32 PM
NOTICE by Ann McKeown Notice of Change of Address (Benitez, Valeria) |
|
| Friday, October 14, 2022 | ||
| 11 | 11
notice
Notice of Appearance
Fri 10/14 2:47 PM
NOTICE of Appearance by Valeria Benitez on behalf of Ann McKeown (Benitez, Valeria) |
|
| Friday, July 22, 2022 | ||
| 10 | 10
notice
Notice of Appearance
Fri 07/22 2:19 PM
NOTICE of Appearance by Reagan Downing on behalf of Ann McKeown (Downing, Reagan) |
|
| Tuesday, March 01, 2022 | ||
| 9 | 9
notice
Notice of Appearance
Tue 03/01 3:17 PM
NOTICE of Appearance by Frederick M. Erny on behalf of CooperSurgical, Inc, Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc. (Erny, Frederick) |
|
| Thursday, January 27, 2022 | ||
| 8 | 8
notice
Notice of Substitution of Counsel
Thu 01/27 12:37 PM
Certification of Consent to Substitution of Counsel. Brittany Rygiel replacing attorney Fatima Abuzerr. (Rygiel, Brittany) |
|
| 7 | 7
notice
Notice (Other)
Thu 01/27 11:23 AM
NOTICE of Change of Counsel by Ann McKeown re6 Notice (Other) (Abuzerr, Fatima) Modified on 1/27/2022 to edit text. (aaq) |
|
| 6 | 6
notice
Notice (Other)
Thu 01/27 11:04 AM
NOTICE by Ann McKeown Certificate of Consent to Substitute Attorney (Abuzerr, Fatima) |
|
| Wednesday, January 26, 2022 | ||
| 5 | 5
notice
Notice of Appearance
Wed 01/26 1:09 PM
NOTICE of Appearance by Brittany Rygiel on behalf of Ann McKeown (Rygiel, Brittany) |
|
| Friday, January 07, 2022 | ||
| 4 | 4
service
Waiver of Service Executed
Fri 01/07 3:14 PM
WAIVER OF SERVICE Returned Executed by Ann McKeown. Teva Branded Pharmaceutical Products R&D, Inc. waiver mailed on 1/3/2022, answer due 3/4/2022; Teva Pharmaceuticals USA, Inc. waiver mailed on 1/3/2022, answer due 3/4/2022; Teva Women's Health, LLC waiver mailed on 1/3/2022, answer due 3/4/2022. (Abuzerr, Fatima) |
|
| 3 | 3
service
Waiver of Service Executed
Fri 01/07 3:13 PM
WAIVER OF SERVICE Returned Executed by Ann McKeown. CooperSurgical, Inc waiver mailed on 1/3/2022, answer due 3/4/2022; The Cooper Companies, Inc. waiver mailed on 1/3/2022, answer due 3/4/2022. (Abuzerr, Fatima) |
|
| Monday, December 20, 2021 | ||
| 2 | 2
6
pgs
order
Order
Tue 12/21 2:32 PM
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021. (anc) |
|
| 1 | 1
7
pgs
cmp
Complaint
Tue 12/21 2:28 PM
SHORT FORM COMPLAINT with Jury Demand filed by Ann McKeown. Direct File MDL-USDC Central District of Illinois (Filing fee $402, receipt number AGANDC-11470486)(anc) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. Modified on 12/21/2021in order to add original district (anc). |
|
|
Att: 1
Civil Cover Sheet
|
||
|
utility
Terminate Civil Case
Tue 12/21 2:33 PM
Civil Case Terminated. (anc) |
||